Tweets
EULAR Abstract Archive
OP0031 (2024)
COMPARATIVE ANALYSIS OF TNF INHIBITORS & IL17 INHIBITORS IN PSORIATIC ARTHRITIS: CARDIOVASCULAR OUTCOMES signif absolute risk diff 3 % ischaemic heart disease 2 % heart failure TNFi vs IL17i https://t.co/fNIiMt4caL. @RheumNow #EULAR2024
Links:
Peter Nash @drpnash ( View Tweet )
1 year 7 months ago
Zoe @ZoeClarkOsteo from @NASSexercise @NASSchiefexec presenting her work from the Your SpAce self-management programme which covers topics on pain, fatigue, flares and much more #EULAR2024 @RheumNow https://t.co/q81JDHu7Oj
Links:
Dr. Antoni Chan @synovialjoints ( View Tweet )
1 year 7 months ago
Grappa « difficult to treat and complex to manage» PsA meeting - SLR, Patient & rheumo survey, working on definition eg - fail 1 csDMARD & 2 bDMARDs different MOA @RheumNow #EULAR2024
Peter Nash @drpnash ( View Tweet )
1 year 7 months ago
CAR-T - autologous vs allogenic , need for full induction , safety of retreatment, CAR-T lymphoma/leukaemia, cost, ideal candidate ? @RheumNow #EULAR2024
Peter Nash @drpnash ( View Tweet )
1 year 7 months ago
opposing point of view to previous post @RheumNow #EULAR2024 https://t.co/T72r8kXF1j
Peter Nash @drpnash ( View Tweet )
1 year 7 months ago
#EULAR2024 POS1325 Childhood onset #lupus is often more severe with high mortality rate. Similar to findings in adults, 2 cSLE patients with refractory disease including failure to CyC, RTX & PLEX responded to CD19 CAR T cells with similar short term safety profile @RheumNow https://t.co/YD2arjxcso
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
1 year 7 months ago
lanalumab (anti-baff) LTE 1/3 to 1/2 LLDAS/DORIS remission at 52 wks, reduction autoabs etc - looking very promising @RheumNow #EULAR2024
Peter Nash @drpnash ( View Tweet )
1 year 7 months ago
Frank Buttgereit discusses potential reason for ceiling effect in RA and questions why we don’t use more combination therapy in RA (including low dose of of GC), using the example of Hypertension guidelines
Is long term low dose GC in RA really a desirable option?
@RheumNow… https://t.co/Nc7lldN7Nd https://t.co/63K96uuhKG
Links:
Aurelie Najm @AurelieRheumo ( View Tweet )
1 year 7 months ago
Tips to help in self-management. Procrastination is a huge barrier to self-management. Delegate and prioritise #EULAR2024 Andrea Marques @RheumNow https://t.co/SbQgOMwqL0
Links:
Dr. Antoni Chan @synovialjoints ( View Tweet )
1 year 7 months ago
Steroids are often started before pts see a rheumatologist
This associates with long-term low-dose steroid use
Need better collaboration between referrers and rheum to reduce this avoidable steroid burden
POS0137 @RheumNow #EULAR2024
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 7 months ago
#EULAR2024 POS0436 Another benefit of T2T to achieve remission by using less NSAIDs, lower GC, earlier use of SFZ, HCQ and TNF-i = shorter Time to Pregnancy from conception in #RA women (median 84 days) vs without pre-counselling & T2T (196 days) @RheumNow https://t.co/2ZpDLmPVt0
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
1 year 7 months ago
Data form TARA trial Taper in RA remission
Flare free survival at 2 yrs 35%
Risk of flare is similar in ACPA+ & ACPA- RA
Risk of flare is similar if taper TNFi first or csDMARD first
@RheumNow #EULAR2024 POS0405 https://t.co/89gAglHUcw
Aurelie Najm @AurelieRheumo ( View Tweet )
1 year 7 months ago
